Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0712
+0.0012 (1.71%)
Oct 2, 2025, 3:43 PM EDT
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $658.04 thousand as of October 3, 2025. Its market cap has decreased by -75.40% in one year.
Market Cap
658.04K
Enterprise Value
1.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 658.04K, a decrease of -97.89%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 658.04K | -86.83% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | 15.90M | -31.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 684.21M |
| Glass House Brands | 634.90M |
| Northwest Biotherapeutics | 372.38M |
| CytoDyn | 330.58M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 287.63M |
| Silence Therapeutics | 245.62M |